Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,495 | 7 | 58.4% |
| Food and Beverage | $1,066 | 28 | 41.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $981.83 | 9 | $0 (2024) |
| Philips North America LLC | $615.60 | 2 | $0 (2024) |
| Esperion Therapeutics, Inc. | $423.01 | 3 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $194.19 | 9 | $0 (2022) |
| HeartFlow, Inc. | $144.94 | 1 | $0 (2023) |
| Kowa Pharmaceuticals America, Inc. | $60.40 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $31.25 | 1 | $0 (2019) |
| Amarin Pharma Inc. | $23.08 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $23.03 | 1 | $0 (2019) |
| Philips Electronics North America Corporation | $19.57 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,611 | 12 | Abbott Laboratories ($981.83) |
| 2023 | $189.37 | 4 | HeartFlow, Inc. ($144.94) |
| 2022 | $83.20 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($47.66) |
| 2021 | $592.62 | 11 | Esperion Therapeutics, Inc. ($423.01) |
| 2019 | $54.28 | 2 | AstraZeneca Pharmaceuticals LP ($31.25) |
| 2018 | $30.56 | 2 | NOVARTIS PHARMACEUTICALS CORPORATION ($17.33) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Abbott Laboratories | — | Travel and Lodging | In-kind items and services | $495.79 | General |
| Category: Structural Heart | ||||||
| 12/20/2024 | Abbott Laboratories | — | Travel and Lodging | In-kind items and services | $60.16 | General |
| Category: Structural Heart | ||||||
| 12/20/2024 | Abbott Laboratories | — | Travel and Lodging | In-kind items and services | $21.21 | General |
| Category: Structural Heart | ||||||
| 12/20/2024 | Abbott Laboratories | — | Travel and Lodging | In-kind items and services | $9.02 | General |
| Category: Structural Heart | ||||||
| 12/19/2024 | Abbott Laboratories | — | Travel and Lodging | In-kind items and services | $292.86 | General |
| Category: Structural Heart | ||||||
| 12/19/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $32.18 | General |
| Category: Structural Heart | ||||||
| 12/19/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $32.18 | General |
| Category: Structural Heart | ||||||
| 12/19/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $32.18 | General |
| Category: Structural Heart | ||||||
| 12/19/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: Structural Heart | ||||||
| 04/03/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/25/2024 | Philips North America LLC | (9525) Intracardiac Und (Device) | Travel and Lodging | In-kind items and services | $319.20 | General |
| Category: Medical Device | ||||||
| 02/25/2024 | Philips North America LLC | (9525) Intracardiac Und (Device) | Travel and Lodging | In-kind items and services | $296.40 | General |
| Category: Medical Device | ||||||
| 11/15/2023 | HeartFlow, Inc. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $144.94 | General |
| Category: Coronary | ||||||
| 11/13/2023 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/16/2023 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/22/2023 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/20/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $15.97 | General |
| Category: Cardiovascular | ||||||
| 10/24/2022 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $19.57 | General |
| Category: Medical Device | ||||||
| 03/11/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: DIABETES | ||||||
| 01/25/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: DIABETES | ||||||
| 12/28/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: DIABETES | ||||||
| 12/07/2021 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/10/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: DIABETES | ||||||
| 11/09/2021 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/05/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $34.49 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,174 | 2,907 | $2.2M | $328,042 |
| 2022 | 17 | 1,544 | 2,090 | $1.5M | $235,450 |
| 2021 | 22 | 2,102 | 2,776 | $2.0M | $325,062 |
| 2020 | 21 | 1,852 | 2,679 | $1.9M | $315,736 |
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 222 | 223 | $671,230 | $91,652 | 13.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 446 | 450 | $787,500 | $78,926 | 10.0% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 227 | 451 | $112,750 | $41,904 | 37.2% |
| 99236 | Initial hospital care with same-day admission and discharge with high level of medical decision making, per day, if using time, at least 85 minutes | Facility | 2023 | 43 | 123 | $85,485 | $23,163 | 27.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 379 | 394 | $137,900 | $22,956 | 16.6% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 115 | 460 | $98,900 | $18,501 | 18.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 99 | 141 | $59,925 | $14,583 | 24.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 225 | 226 | $101,700 | $12,760 | 12.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 30 | 30 | $21,000 | $5,818 | 27.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 26 | $16,900 | $4,111 | 24.3% |
| 78803 | Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | Office | 2023 | 12 | 12 | $18,000 | $4,080 | 22.7% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 30 | 30 | $16,500 | $2,825 | 17.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 15 | 15 | $5,250 | $1,575 | 30.0% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 26 | 26 | $7,150 | $1,386 | 19.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 49 | 53 | $7,420 | $1,159 | 15.6% |
| 93352 | Injection of x-ray contrast during ultrasound of heart | Facility | 2023 | 19 | 19 | $2,850 | $580.14 | 20.4% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 30 | 30 | $2,700 | $469.50 | 17.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 39 | 55 | $1,925 | $453.60 | 23.6% |
| A9538 | Technetium tc-99m pyrophosphate, diagnostic, per study dose, up to 25 millicuries | Office | 2023 | 12 | 12 | $1,800 | $264.12 | 14.7% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 12 | 12 | $1,200 | $223.56 | 18.6% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 32 | 32 | $1,280 | $206.08 | 16.1% |
| J0280 | Injection, aminophyllin, up to 250 mg | Office | 2023 | 22 | 22 | $550.00 | $156.65 | 28.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 12 | 12 | $840.00 | $148.56 | 17.7% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 53 | 53 | $1,060 | $141.51 | 13.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 178 | 178 | $535,780 | $77,125 | 14.4% |
About Jennifer Chen
Jennifer Chen is a Nuclear Cardiology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2010. The National Provider Identifier (NPI) number assigned to this provider is 1982920716.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jennifer Chen has received a total of $2,561 in payments from pharmaceutical and medical device companies, with $1,611 received in 2024. These payments were reported across 35 transactions from 13 companies. The most common payment nature is "Travel and Lodging" ($1,495).
As a Medicare-enrolled provider, Chen has provided services to 7,672 Medicare beneficiaries, totaling 10,452 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Practice Information
- Specialty Nuclear Cardiology
- Other Specialties Cardiovascular Disease
- Location New York, NY
- Active Since 04/19/2010
- Last Updated 01/28/2021
- Taxonomy Code 207UN0901X
- Entity Type Individual
- NPI Number 1982920716
Products in Payments
- (9525) Intracardiac Und (Device) $615.60
- NEXLIZET (Drug) $423.01
- JARDIANCE (Drug) $194.19
- FFRct (Device) $144.94
- LIVALO (Drug) $44.43
- BRILINTA (Drug) $31.25
- Vascepa (Drug) $23.08
- ELIQUIS (Drug) $23.03
- (5044) MCOT (Device) $19.57
- PAZEO (Drug) $17.33
- Livalo (Drug) $15.97
- LINZESS (Drug) $13.59
- CARDIOGEN (Drug) $13.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nuclear Cardiology Doctors in New York
Dr. Klaus Rentrop, M.d, M.D
Nuclear Cardiology — Payments: $11.7M
Samuel Kim
Nuclear Cardiology — Payments: $6,833
Dr. Saaron Laighold, M.d, M.D
Nuclear Cardiology — Payments: $3,519
David Bolon
Nuclear Cardiology — Payments: $1,757
Dr. Marc Nolan, M.d, M.D
Nuclear Cardiology — Payments: $1,751
Stephen Mccullough, Md, MD
Nuclear Cardiology — Payments: $899.48